Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Intel Surviving the PC Decline?

With PC sales falling (market researchers have estimated an 8% drop over the last year, we certainly wouldn’t say it’s a good time to be Intel Corporation (NASDAQ:INTC). The company recently reported its results for the third quarter of 2012, in which its revenue decreased by 5% versus the same period last year and with Intel struggling to cut costs earnings ended up down 14%. However, the reported numbers were considerably higher than Wall Street analysts had expected, suggesting that the large tech company was not taking as many hits from industry trends as one might think. Intel did cut its guidance for revenue and for gross margins for the fourth quarter of the year, which likely contributed to the stock’s 3% decline on the release.

We see the sell-side expecting $2.13 per share in earnings in 2013, which is up only slightly from what Intel Corporation is expected to do this year. This earnings per share figure implies a forward P/E of only 10. Even though analysts do not seem particularly optimistic, the five-year PEG ratio is 0.9. Therefore, on a quantitative basis Intel- which, let’s recall, has a market capitalization of over $100 billion and pays a dividend yield of 4.1% at current prices (with a recent history of dividend increases)- looks very much like a value stock. The company only has to match analyst expectations- or even slightly underperform them- in order to justify its current stock price. With the consensus for next year not being particularly optimistic, we think there’s a good chance of Intel getting there.


Lansdowne Partners, managed by Paul Ruddock and Steve Heinz, increased its stake in Intel Corporation by 9% during the second quarter and the company was one of the five largest positions in the fund’s 13F portfolio (see more stock picks from Lansdowne Partners). Renaissance Technologies, whose success made founder Jim Simons a billionaire, also added shares of Intel and owned a total of 17 million shares at the end of June (find more stocks that Renaissance Technologies owns).

The closest peer for Intel is competing chipmaker Advanced Micro Devices, Inc. (NYSE:AMD). Read our recent article focusing on AMD. Now below a market cap of $2 billion- the stock is down 51% year to date- and unprofitable, AMD is not handling the shrinkage of the PC market as well as Intel is. In the second quarter of the year, its revenue was down 10% and its earnings were down 39% compared to the same period in the previous year. Based on analyst expectations the forward P/E is 25; that is high and we doubt that a declining company in a declining industry is going to start generating positive profits in just a couple quarters.

We can also compare Intel to Texas Instruments Incorporated (NASDAQ:TXN) and semiconductor companies Maxim Integrated Products Inc. (NASDAQ:MXIM) and STMicroelectronics N.V. (NYSE:STM). Texas Instruments and Maxim both trade at 21 times trailing earnings- a considerable premium to Intel, though these peers are not as dependent on personal computers. However, both saw their earnings decrease at double-digit rates in their most recent quarter compared to the same period a year earlier; revenue declined as well. Despite this, analyst consensus is for strong earnings growth in 2013 and their forward P/E multiples are in the 13-14 range. Again, this is well higher than where Intel trades. STMicroelectronics is unprofitable, but like at AMD Wall Street analysts expect positive earnings next year; it trades at 16 times their estimates for 2013. This is a higher multiple than at Intel, again, and depends on the company breaking into the black. Its revenue has been down, and we don’t think that it is a buy either.

When we look at the Intel the company, we’re quite pessimistic. We doubt that revenue growth is going to be strong, or even weakly positive, for a while. However, the stock is cheap and with a good dividend as well we think it is a buy relative to its peers.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!